Dr. Jennifer Donegan: Novel gene therapy reduces schizophrenia symptoms

Dr. Jennifer Donegan, GSBS alumna and postdoctoral fellow at UT Health San Antonio was featured for her findings in preclinical testing that, capsazepine analogs have shown promise in killing oral cancer tumors while sparing healthy tissue.
Read article from the San Antonio Express-News

In preclinical testing, capsazepine analogs have shown promise in killing oral cancer tumors while sparing healthy tissue.
Photo: Adam Gault, Getty Images/OJO Images RF

Article Categories: News